Jayanthi Suryakumar

Title: Jayanthi Suryakumar: Innovator in Pharmaceutical Formulations

Introduction

Jayanthi Suryakumar is a prominent inventor based in Hyderabad, Telangana, India. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. Her work focuses on improving the efficacy and delivery of medications, which is crucial for patient care.

Latest Patents

Jayanthi holds a patent for an extended release formulation of a direct thrombin inhibitor. The patent, titled "Extended release formulations of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide (DPOC-4088)," provides a solution for better control of blood plasma levels. This formulation maintains substantially constant plasma levels of the active ingredient for at least about 16 hours, allowing for once-daily dosing. This innovation is expected to enhance patient compliance and therapeutic outcomes.

Career Highlights

Jayanthi is currently employed at Diakron Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating formulations that improve the delivery and effectiveness of critical medications.

Collaborations

Throughout her career, Jayanthi has collaborated with notable colleagues, including Sankar Ramakrishnan and Elumalal Venkatesan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jayanthi Suryakumar is a trailblazer in the pharmaceutical industry, with her innovative patent contributing to advancements in drug delivery systems. Her dedication to improving patient care through her work at Diakron Pharmaceuticals, Inc. highlights her commitment to the field.